-
Sort By
-
Newest
-
Newest
-
Oldest
-
All Categories
-
All Categories
-
Alternatives
-
ASX
-
Crypto
-
ESG
-
ETFs
-
Global
-
Growth
-
IPO
-
M&A
-
Small caps
-
Unlisted Assets
-
Value
The Crown Resorts Ltd (ASX: CWN) share price has leapt 8% in morning trade after receiving a revised takeover bid of $13.10 per share from private equity outfit Blackstone. Currently, the Crown share price is at $12.55 per share, 4.2% below the indicative offer price. CWN share price Fourth time lucky In November, Blackstone proposed $12.50 per share for Crown, which was…
Microsoft (NASDAQ:MSFT) is back. The 46-year old, $2.3 trillion-dollar company has had its status raised back to FANG rank, taking the place of Twitter (NYSE:TWTR) in the Intercontinental Exchange NYSE FANG+ index. ETF Securities FANG+ ETF (ASX:FANG) was quick to make the change, replacing Twitter in the first reconstitution of the fund since it was…
As the calendar turns over to another year the bubble talk picks up once again. Listening to a popular US podcast called Animal Spirits during the week they referred to the acronym ‘FUD’ referring to Fear, Uncertainty and Doubt. Specifically, the hosts were referring to the power of negative headlines, talking about bubbles, busts valuations,…
This week fund manager VGI Partners (ASX:VGI) has ended media rumours by confirming it is looking to merge with a fellow fund manager. While speculation has been rife, and the company says there are several parties under consideration, it seems that Regal Funds Management and Challenger are the two names being touted by financial media….
The Afterpay Ltd (ASX: APT) share price is on watch after the final timetable regarding its merger with Block Inc (NYSE: SQ) was released. What’s happening? The ASX’s biggest buy-now, pay-later player is getting close to merging, or being taken over, by Block (formerly called Square). It has been a long time coming. When takeovers are announced, particularly ones…
In the fifth and final part of 22 ASX shares for 2022, we’ll be taking a look at four companies with big growth prospects. If you haven’t already, check out the release of Part 1, Part 2, Part 3 and Part 4. 1. Uniti Group Ltd (ASX: UWL) In a market that is rewarding cash-generating businesses with long growth runways,…
To start the year, I’ve provided a quick round up of some of the more popular ETFs available to Australian investors, with a particular focus on secular and thematic opportunities within global equities. ETF: iShares Asia 50 ETF (ASX: IAA) Summary: Largest 50 Asian shares ex Japan Asian equity markets continued to underperform as global…
With 2021 done and dusted, Morningstar has released its monthly Best Stock Ideas, which highlight high-quality Australian and New Zealand companies that are trading at a discount to their fair value. The latter is important in this regard, as the group has a decidedly ‘value’ focus. From nearly 200 companies in its research list, Morningstar…
Rates send markets lower, Magellan loses ‘material’ client, gold miners shine The local market benefitted from a strong overseas lead but managed to deliver a gain of just 0.1 per cent on Friday. The technology sector continues to be the largest drag, falling 3.9 per cent for the day and 4.5 per cent for the week, with energy…
Market weaker despite positive lead, unemployment falls, CSL down on acquisition The S&P/ASX200 (ASX: XJO) didn’t follow global markets higher, finishing down 0.4 per cent as CSL (ASX: CSL) dragged both the healthcare sector, down 5.1 per cent and the market lower. The reason was the completion of their capital raising at an 8 per…
Tech pulls market lower, deals galore across travel, property sectors The technology sector once again dragged the market lower, falling 2.6 per cent and pulling the market down 0.7 per cent along with it. The biggest detractors were Afterpay (ASX: APT) and Zip Co (ASX: Z1P) which fell 3.1 and 6.9 per cent respectively as the flood out of high…
CSL Limited (ASX: CSL) has announced a blockbuster US$12.3 billion (AU$17.2 billion) tender offer for Vifor Pharma after trading hours today. The deal is CSL’s first major transaction since 2008 and will bring together two globally leading biotech companies. CSL finishes the year with a bang Speculation around the deal had been gaining momentum in recent days. On Monday CSL confirmed discussions…